Miyanaga A - Search Results

1

Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer.

Hisakane K, Seike M, Sugano T, Matsuda K, Kashiwada T, Nakamichi S, Matsumoto M, Miyanaga A, Noro R, Kubota K, Gemma A. Hisakane K, et al. Among authors: miyanaga a. Gene. 2023 Mar 20;857:147177. doi: 10.1016/j.gene.2023.147177. Epub 2023 Jan 7. Gene. 2023. PMID: 36623674

2

Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.

Masuda M, Chen WY, Miyanaga A, Nakamura Y, Kawasaki K, Sakuma T, Ono M, Chen CL, Honda K, Yamada T. Masuda M, et al. Among authors: miyanaga a. Mol Cell Proteomics. 2020 Jan;19(1):223. doi: 10.1074/mcp.AAC119.001903. Mol Cell Proteomics. 2020. PMID: 31894100 Free PMC article. No abstract available.

3

PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

Noro R, Gemma A, Miyanaga A, Kosaihira S, Minegishi Y, Nara M, Kokubo Y, Seike M, Kataoka K, Matsuda K, Okano T, Yoshimura A, Kudoh S. Noro R, et al. Among authors: miyanaga a. Int J Oncol. 2007 Nov;31(5):1157-63. Int J Oncol. 2007. PMID: 17912443

4

E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib.

Miyanaga A, Gemma A, Ando M, Kosaihira S, Noro R, Minegishi Y, Kataoka K, Nara M, Okano T, Miyazawa H, Tanaka T, Yoshimura A, Kobayashi K, Iwanami H, Hagiwara K, Tsuboi E, Kudoh S. Miyanaga A, et al. Oncol Rep. 2008 Feb;19(2):377-83. Oncol Rep. 2008. PMID: 18202784

5

Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model.

Miyanaga A, Gemma A, Noro R, Kataoka K, Matsuda K, Nara M, Okano T, Seike M, Yoshimura A, Kawakami A, Uesaka H, Nakae H, Kudoh S. Miyanaga A, et al. Mol Cancer Ther. 2008 Jul;7(7):1923-30. doi: 10.1158/1535-7163.MCT-07-2140. Epub 2008 Jul 7. Mol Cancer Ther. 2008. PMID: 18606719

6

The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application.

Noro R, Miyanaga A, Shimokawa T, Kuribayashi H, Mizutani H, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A. Noro R, et al. Among authors: miyanaga a. J Nippon Med Sch. 2009 Feb;76(1):44-6. doi: 10.1272/jnms.76.44. J Nippon Med Sch. 2009. PMID: 19305113 Free article. No abstract available.

7

Phase II study of nimustine hydrochloride (ACNU) plus paclitaxel for refractory small cell lung cancer.

Isobe K, Kobayashi K, Kosaihira S, Kurimoto F, Sakai H, Uchida Y, Nagai Y, Yamaguchi T, Miyanaga A, Ando M, Mori G, Hino M, Gemma A. Isobe K, et al. Among authors: miyanaga a. Lung Cancer. 2009 Dec;66(3):350-4. doi: 10.1016/j.lungcan.2009.03.003. Epub 2009 Apr 1. Lung Cancer. 2009. PMID: 19342118 Clinical Trial.

8

Histone deacetylase inhibitor enhances sensitivity of non-small-cell lung cancer cells to 5-FU/S-1 via down-regulation of thymidylate synthase expression and up-regulation of p21(waf1/cip1) expression.

Noro R, Miyanaga A, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A. Noro R, et al. Among authors: miyanaga a. Cancer Sci. 2010 Jun;101(6):1424-30. doi: 10.1111/j.1349-7006.2010.01559.x. Epub 2010 Mar 10. Cancer Sci. 2010. PMID: 20384633 Free article.

9

[Pleuritis carcinomatosa].

Miyanaga A, Gemma A. Miyanaga A, et al. Gan To Kagaku Ryoho. 2011 Apr;38(4):524-7. Gan To Kagaku Ryoho. 2011. PMID: 21498978 Japanese.

10

Enzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.

Shimokawa T, Seike M, Soeno C, Uesaka H, Miyanaga A, Mizutani H, Kitamura K, Minegishi Y, Noro R, Okano T, Yoshimura A, Gemma A. Shimokawa T, et al. Among authors: miyanaga a. Br J Cancer. 2012 Feb 28;106(5):867-75. doi: 10.1038/bjc.2012.7. Epub 2012 Feb 14. Br J Cancer. 2012. PMID: 22333600 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

147 results

Search Page